Why is Par Drugs & Che. falling/rising?

As of 23-Sep, Par Drugs & Chemicals Ltd is experiencing a decline in its stock price, currently at 109.07, which reflects a decrease of 3.35 or 2.98%. The stock has underperformed its sector today by 2.42%, and while it is trading above its 20-day, 50-day, and 100-day moving averages, it is below its 5-day and 200-day moving averages. Over the past week, the stock has decreased by 1.78%, and its year-to-date performance shows a significant drop of 45.16%. The company has faced challenges, including negative results for the last three consecutive quarters and a substantial year-over-year decline of 55.19% in stock returns, indicating poor long-term growth prospects despite a low debt-to-equity ratio and attractive valuation metrics.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as the Sensex has only declined by 0.28% over the past week and has gained 6.45% year-to-date. This underperformance highlights the company's struggles compared to the overall market, where even negative returns have been less severe. The company's net sales growth of 12.10% and operating profit growth of just 1.10% over the last five years further emphasize its difficulties in achieving sustainable growth, contributing to investor sentiment that may be driving the stock price lower.